An Ethics First Approach to Genetic Research and Drug Development with Sarah LeBaron von Baeyer
Release Date:
This is a free preview of a paid episode. To hear more, visit www.mendelspod.comSarah LeBaron von Baeyer studied anthropology at Yale. Today she serves as the Director of Ethics Engagement at the new drug development company, Variant Bio, not a job she ever imagined at university.
An Ethics First Approach to Genetic Research and Drug Development with Sarah LeBaron von Baeyer